Teva Pharmaceutical Industries
NYSE: TEVA
Does it really matter?
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.Statin Users May Have a Reason to Rejoice After This Data
An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.